The FDA approved

INVEGA SUSTENNA

in 2009. It is a long-acting injectable intended for adults with schizophrenia or schizoaffective disorder. However, it has been prescribed widely off-label to adolescents, foster children, and incarcerated individuals.

Doomed by Design: How a Dangerous Drug, a Broken System, and a Failing DA Failed A Mentally Ill Teen

Robbie Robertson·Civil Rights·March 27, 2025·

https://theokpost.com/civil-rights/doomed-by-design-how-a-dangerous-drug-a-broken-system-and-a-failing-da-failed-a-mentally-ill-teen/2025/03/27/

Despite being approved for schizophrenia in children aged 12-17, Johnson & Johnson’s own website admits that “the safety and effectiveness of INVEGA SUSTENNA in patients <18 years of age have not been established.” Yet their billion-dollar marketing campaign continues unabated.

Peyton Moyer, a mentally ill man from Watkinsville, Georgia, was sentenced to life in prison at age 19. He was charged in a high-profile double homicide case involving the deaths of his mother, Ashley Shutza, and boyfriend Benjamin Smith. Mainstream media sensationalized the case, presenting it as a cut-and-dry murder without regard for mental health, medication side effects, or the role of systemic failure. Articles by outlets such as People Magazine, Fox 5 Atlanta, and Oxygen provided the public only one side of the story—a side devoid of crucial context.

What the public doesn’t know is this: Peyton was under the influence of paliperidone palmitate, a powerful antipsychotic drug known as INVEGA SUSTENNA®. It was administered to him as a teenager—against the will of his father, Gregory Moyer, and without informed consent. No comprehensive evaluation was performed, and tragically, the medical records were never made available to the court until the final day of trial.

Deborah Gonzalez: Same DA, Same Failures

Peyton Moyer was prosecuted by Athens District Attorney Deborah Gonzalez, the same controversial prosecutor now under scrutiny in the case of Laken Riley, the Georgia college student tragically killed in 2024. Gonzalez’s prosecutorial decisions have outraged many, particularly among Trump supporters, parents, and advocates of justice reform, who are increasingly alarmed by her pattern of negligence and political posturing.

Big Pharma and Government in Lockstep

The Moyers argue that since the Affordable Care Act, HHS has increasingly functioned as a marketing branch for Big Pharma instead of protecting consumers. Vulnerable children in foster care and the juvenile justice system are disproportionately targeted.

According to a Massachusetts DCF study, 20% of foster children are prescribed psychotropic drugs at dosages exceeding FDA guidelines. Other states, like California, require oversight. Federally, however, there are no such requirements.

In recent years, the misuse of psychotropic medications among vulnerable children, particularly those in foster care, has become alarmingly common. According to recent studies, nearly 40% of children in the foster care system are prescribed psychotropic drugs—often in doses exceeding FDA guidelines and without proper oversight (Massachusetts Department of Children and Families Study). While these potent drugs are liberally prescribed to address behavioral or emotional challenges, rarely does the CDC or other public health agencies invest similar resources or emphasis in promoting holistic approaches such as exercise, diet, and mental wellness programs—strategies known to significantly improve mental health in children. This stark disparity highlights a deeply flawed system, prioritizing pharmaceutical interventions over safer, more effective, and less invasive methods of care.

The Overmedication of Youth: A Call for Holistic Approaches

The overprescription of psychotropic medications among foster children is a pressing concern. Studies indicate that youth in foster care are prescribed psychotropic drugs at rates 2.7 to 4.5 times higher than non-foster children covered by Medicaid. This trend underscores the urgent need for alternative interventions.​

Read moar:

https://theokpost.com/civil-rights/doomed-by-design-how-a-dangerous-drug-a-broken-system-and-a-failing-da-failed-a-mentally-ill-teen/2025/03/27/

>>23674325

Used off label minors

INVEGA SUSTENNA

Moments After Killing Both His Parents

891,840 views · 2 weeks ago

Police Insider

900K

https://youtu.be/PwEqxC_BuAo

I did overnight respite for these kids in group homes. Startling to see how they MUST takr RX’s. All of the kids were on drugs on schedules. Even the toddlers. Very gross. Nice kids, funny, smart, then made to take these zombie drugs because in the system.

Tragic.

Also, pedo types run these respite and foster houses. The vibe of these places is sinister. The kids know it. One teen would sleep fully dressed and kept his shoes on. I asked him why and he just glared at me.

Another very little boy, slept in the strangest position, on knees face dow, butt up in air. Very creepy and sad.

All made to take RX night and day. Checklists.

Some of the kids, teens also gave off future pedo vibes and actions. I think these places are mills for this shit and RX’s keep them silent or labelled crazy.

Creepy adults run and work these jobs. I saw add for overnight respite, meaning cleaning up while day people slept overnight.

Laundry, etc. They found reason to let me go when I was pointing stuff out to the guy who hired me. I realize now that was why. I was a noticer. Fired.

>>23674325

>>23674325

Articles like The Marshall Project’s influential piece, “A Drug Company Says This Shot Will Keep You Out of Prison”, heavily promoted the purported benefits of Invega Sustenna (paliperidone palmitate), positioning it as a groundbreaking solution. However, post-market realities tell a darker and far more troubling story. Reported side effects from actual patients include renal toxicity, rhabdomyolysis, severe motor impairment, increased aggression, psychotic breaks, and even death. Despite the known and documented risks, Johnson & Johnson has continued aggressive marketing of the drug, relying on incomplete and ongoing studies—such as the Johns Hopkins IRB00331222 study—as late as 2024 to legitimize their claims.

>>23674325

>>23674420

This persistent promotion and inadequate disclosure by Johnson & Johnson potentially violates several critical consumer protection and pharmaceutical safety laws. Under federal statutes such as the Federal Food, Drug, and Cosmetic Act (21 U.S.C. § 301 et seq.), pharmaceutical companies have a legal obligation to ensure thorough testing, accurate labeling, and timely disclosure of all known side effects and risks associated with their products. Further, the continued marketing and sales of a potentially harmful medication, absent sufficient safety data—especially when marketed toward vulnerable populations such as children or mentally ill adolescents—can constitute violations subject to significant penalties.

Moreover, the company’s failure to disclose accurate risk information fully may constitute violations under the False Claims Act (31 U.S.C. §§ 3729–3733), which imposes liability on entities that knowingly present or cause false or fraudulent claims to the government for approval or payment. If Johnson & Johnson presented incomplete or misleading safety data to the FDA, HHS, or state agencies to secure approvals or insurance reimbursements, such actions could trigger civil and criminal liabilities.

Meanwhile, families like the Moyers faced systemic obstruction and stonewalling at multiple levels of government. Their earnest attempts to report the harmful drug through FDA channels resulted only in circular automated replies from MedWatch, the FDA’s adverse event reporting system. The withholding of critical medical records in Peyton’s criminal trial until the last possible moment potentially breaches constitutional guarantees of due process under the Fifth and Fourteenth Amendments, as the defense was deprived of essential evidence necessary for effective advocacy.

These agencies’ collective failures raise urgent questions about potential violations of federal statutes mandating transparency and accountability, including the Administrative Procedure Act (5 U.S.C. § 551 et seq.), which demands transparency and responsiveness from federal agencies. Moreover, failure to disclose relevant medical and pharmaceutical records to the courts and impacted families might also violate HIPAA Privacy Regulations (45 CFR Part 160 and Subparts A and E of Part 164), specifically regulations requiring accurate, timely, and authorized sharing of medical records to involved parties.

As public agencies and pharmaceutical giants continue to evade responsibility, American families suffer profound and lasting harm. For the Moyers and many others, genuine accountability means a comprehensive investigation by the Department of Justice, potential litigation to hold Johnson & Johnson accountable, and significant regulatory reforms within FDA and HHS to ensure tragedies like Peyton’s never happen again.

Read moar:

https://theokpost.com/civil-rights/doomed-by-design-how-a-dangerous-drug-a-broken-system-and-a-failing-da-failed-a-mentally-ill-teen/2025/03/27/

Don’t Take Invega Before Watching This

https://youtu.be/9PXBJqQuGSE

They give this seniors in senior care for dementia.

They die sooner.

Tell your family.

>>23674436